Riskpilot← Back to searchSign inGet full accessUgglan Vårdgruppen AB
ABIn liquidationOrg 5568550270Mölndalsvägen 77 2trGeneral medical practice activities · NACE 8621Est. 20110 employees
Revenue 2025
SEK 0
EBITDA margin
—
+42% vs 2024
Equity ratio
92.2%
Financial strength
Net profit 2025
SEK -5K
+50% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -37K | +42% |
| Net profit | SEK -5K | +50% |
| Total assets | SEK 128K | -99% |
| Equity | SEK 118K | -97% |
| Employees | 0 | — |
Legal name
Ugglan Vårdgruppen AB
Org number
5568550270
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 juni 2011
Share capital
SEK 87 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn likvidatorsuppleanten externa firmatecknarna
Company purpose
Bolaget skall bedriva hälso- och sjukvård samt utbildning och konsultverksamhet inom hälso- och sjukvård och därmed förenlig verksamhet.
Address
Mölndalsvägen 77 2tr
Phone
+46313803000
Email
jorgen.svedberg@ugglansvc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 360 | −0 | 0 | 0 |
| Staff expenses | — | −11 | −0 | — | — |
| EBITDA | −308 | −147 | −81 | −64 | −37 |
| Depreciation & amort. | −0 | — | — | −0 | −0 |
| EBIT | −308 | −147 | −81 | −64 | −37 |
| Net financials | −9 | −1 | 276 | −54 | −650 |
| Profit before tax | −18 | −2 | −5 | −10 | −5 |
| Tax | −0 | — | — | −0 | −0 |
| Net profit | −18 | −2 | −5 | −10 | −5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 069 | 5 412 | 4 840 | 9 183 | 128 |
| Equity | 4 609 | 4 608 | 4 602 | 4 593 | 118 |
| Long-term debt | 0 | — | — | 4 809 | 0 |
| Short-term debt | 460 | 804 | 238 | −218 | 10 |
| Total debt | 460 | 804 | 238 | 4 591 | 10 |
EBITDA margin
-3700000.0%
This company
15.8%
Market median
-23417822% vs market
20212025
Equity ratio
92.2%
This company
38.2%
Market median
+141% vs market
20212025
Return on equity
-4.2%
This company
18.4%
Market median
-123% vs market
20212025
Net profit margin
-500000.0%
This company
8.1%
Market median
-6172940% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (10) | ||
JA Liquidator | Liquidator | 2026 |
OJ External Signatory | External Signatory | 2022 |
GU Liquidator | Liquidator | 2026 |
JJ Chief Auditor | Chief Auditor | 2025 |
AS External Signatory | External Signatory | 2026 |
AM External Signatory | External Signatory | 2026 |
MA External Signatory | External Signatory | 2022 |
AP Chief Executive Officer | Chief Executive Officer | 2022 |
KN Audit | Audit | 2026 |
AC Auditor Substitute | Auditor Substitute | 2026 |
| Former (4) | ||
LM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2022 |
ÅM Audit | Audit | 2021 – 2022 |
AL Chief Auditor | Chief Auditor | 2020 – 2021 |
JO Chief Auditor | Chief Auditor | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEHILÄINEN OY
Ugglan Vårdgruppen AB Board members of Ugglan Vårdgruppen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Anders Fredrik Lovén | Liquidator | 0 companies |
| Louise Marlene Fredin | Deputy Chief Executive Officer | 0 companies |
| Olof Jörgen Svedberg | External Signatory | 0 companies |
| Gerd Ulla Marina Jonsson | Liquidator | 0 companies |
| John Joakim Holmquist | Chief Auditor | 0 companies |
| Anna Stina Hammarström | External Signatory | 0 companies |
| Aline Madeleine Pettersson | External Signatory | 0 companies |
| Matti Artturi Schmidt | External Signatory | 0 companies |
| Åsa Maria Jeanson | Audit | 0 companies |
| Anders Lennart Nilsson | Chief Auditor | 0 companies |
| Anders Peter Mikael Westerholm | Chief Executive Officer | 0 companies |
| Karl Niklas Nyberg | Audit | 0 companies |
| Ann Charlott Bouvin | Auditor Substitute | 0 companies |
| Jens Oscar Simon Bertling | Chief Auditor | 0 companies |
| Sami Jukka Petteri Koski | Board of Directors | 0 companies |
| Ingrid Helena Thulin | Board of Directors | 0 companies |
| Herkko Sampa Soininen | Chairman | 0 companies |
| Kaisla Elina Lahdensuo | Board of Directors | 0 companies |
| Markku Eero Antero Näreneva | Board of Directors | 0 companies |
| Kaj Pontus Johansson | Board of Directors | 0 companies |